Paclitaxel (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Paclitaxel drug offered from Actavis Pharma, Inc.. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Paclitaxel |
SUBSTANCE NAME: | PACLITAXEL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-01-05 |
END MARKETING DATE: | 0000-00-00 |
Paclitaxel HUMAN PRESCRIPTION DRUG Details:
Item Description | Paclitaxel from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 6(mg/mL) |
START MARKETING DATE: | 2015-01-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 45963-613_e05de12f-95ed-4e13-b67b-d1e2a94679bb |
PRODUCT NDC: | 45963-613 |
APPLICATION NUMBER: | ANDA090130 |
Other PACLITAXEL Pharmaceutical Manufacturers / Labelers: